Abstract
Renal cell carcinoma accounts for 3–4% of adult malignant neoplasms and over 65,000 new cases of kidney cancer were diagnosed in the USA in 2013 [1, 2]. Widespread use of abdominal imaging is leading to an increased incidence in the detection of small renal masses (SRMs) among other causes [1–4]. In light of recent literature on the role of percutaneous renal mass biopsy and retrospective data analysis, surveillance for renal masses ≤4 cm is likely to become more common especially in patients with less aggressive pathology, advanced age and multiple medical comorbidities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Borghesi M, Brunocilla E, Volpe A, Dababneh H et al (2015) Active surveillance for clinically localized renal tumors: an updated review of current indications and clinical outcomes. Int J Urol 22:432–438
Mehrazin R, Smaldone M, Kutikov A, Li T et al (2014) Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol 192:659–664
Silverman S, Israel G, Trinh G (2015) Incompletely characterized renal masses: emerging data support conservative management. Radiology 275(1):28–42
Organ M, Jewett M, Basuik J et al (2014) Growth kinetics of small renal masses: a prospective analysis from the renal cell consortium of Canada. Can Uro Assoc J 8:432–438
Pierorazio P, Johnson M, Ball M, Gorin M et al (2015) Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol 68:408–415
Mason RJ, Abdolell M, Trottier G et al (2011) Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 59:863–867
Schiavina R, Borghesi M, Dababneh H et al (2014) Smal renal masses managed with active surveillance: predictors of tumor growth rate after long-term follow-up. Clin. Genitourin. Cancer 13(2):87–92
Haramis G, Mues AC, Rosales JC et al (2011) Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology 77:787–791
Jewett MA, Mattar K, Basiuk J et al (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60:39–44
Abouassaly R, Lane BR, Novick AC (2008) Active surveillance of renal masses in elderly patients. J Urol 180:505–508
Rosales JC, Haramis G, Moreno J et al (2010) Active surveillance for renal cortical neoplasms. J Urol 183:1698–1702
Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG (2009) Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 115:2844–2852
Brunocilla E, Borghesi M, Schiavina R et al (2014) Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. Clin Genitourin Cancer 12:178–181
Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S (2007) Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110:1010–1014
Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745
Chawla SN, Crispen PL, Hanon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431
Halverson SJ, Kunju LP, Bhalla R et al (2013) Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol 189:441–446
Ljungberg B, Bensalah K, Bex A. et al. (2011) Guidelines on renal cell carcinoma. Eur Urol. http://www.uroweb.org/gls/pdf/10%20Renal%20Cell%carcinoma_LR.pdf
Volpe A, Jewett MA (2009) Current role, techniques and outcomes of percutaneous biopsy of renal tumors. Expert Rev Anticancer Ther 9:773
Cambpbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management f the clinical T1 renal mass. J Urol 182:1271–1279
Leveridge MJ, Finelli A, Kachura JR et al (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutanous biopsy, and the roles of repeat biopsy. Eur Urol 60:578–584
Zargar H, Atwell TD, Cadeddu JA, Rosette J et al (2015) Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. doi:10.1016/j.eururo.2015.03.027
Zargar H, Samarasekera D, Khalifeh A, Remer EM, O’Malley C et al (2015) Laparoscopic vs. percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urol 85(3):850–855
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erpelding, S.G., Walker, J. & Venkatesh, R. Current Role of Active Surveillance in the Management of a Small Renal Mass. Indian J Surg Oncol 8, 403–406 (2017). https://doi.org/10.1007/s13193-016-0600-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-016-0600-7